Sanofi has filed a patent-infringement suit against Merck Sharp & Dohme Corp. in the US District Court for the District of Delaware alleging the infringement of 10 patents related to its…
GlaxoSmithKline (GSK) has appointed Emma Walmsley to the position of chief executive officer (CEO) designate, effective on March 31, 2017 when the current GSK CEO, Andrew Witty, retires. Ms. Walmsley…
Allergan to Acquire Tobira Therapeutics in $1.7 Billion Deal
Allergan has agreed to acquire Tobira Therapeutics, a South San Francisco-based clinical-stage biopharmaceutical company focused on non-alcoholic steatohepatitis (NASH) and other liver diseases, for an upfront payment of $28.35 per…
Novo Nordisk Gets Positive CHMP Opinion for Extended Insulin Use
Novo Nordisk has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency to extend the use of NovoRapid (insulin aspart)…
Teva Pharmaceutical Industries has formed a collaboration with Intel Corporation to develop a wearable device and machine-learning platform for use in Huntington disease (HD). This platform will continuously monitor and…
GSK Addresses Global Health Challenges; Plans to Create a GSK-Led Biopreparedness Organization
GlaxoSmithKline (GSK) has announced it will set out a series of steps to further address emerging global health challenges as the United Nations General Assembly takes place in New York…
Delaware Court Rules Against Shire’s Lialda Patent
A US district court has ruled against a patent held by Shire for Lialda (mesalamine), Shire’s drug for inducting remission in patients with active, mild-to-moderate ulcerative colitis (UC) and for…
Gerresheimer to Sell Life-Science Research Business
Gerresheimer, a manufacturer of special glass and plastic products to the pharmaceutical industry, plans to sell its life-science research business to Duran group, a portfolio company of One Equity Partners,…
Takeda Gets Positive European Opinion for Multiple Myeloma Drug
Takeda Pharmaceutical has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommending the conditional approval of Ninlaro (ixazomib) capsules in combination…
Amgen Gets Positive European Opinion for HPT Drug Parsabiv
Amgen has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency for the marketing authorization of Parsabiv (etelcalcetide) for treating…